Your institution may have access to this item. Find your institution then sign in to continue.
Title
Good 2016 for US pharma.
Abstract
The article offers information on increase in earnings and sales in the U.S. pharmaceutical industry in 2016. Topics discussed include rise in operating profit and sales at Abbott while meeting financial commitments; increase in operating profit and sales for AbbVie while reflecting strong growth and confidence in 2017; and rise in pre-tax profit, sales, and profit at Bristol-Myers Squibb.